Deathstalker Scorpion

David Hume Kennerly
Wherever history has happened for over 40 years, David Hume Kennerly has been there to document it with a vision and eye for capturing the most poignant moments in a way that is almost uncanny.

David spent two years in Vietnam literally in the line of fire, recording some of the most emotional and controversial events this country has ever experienced. His work there garnered a Pulitzer Prize.

Upon returning home, he and his camera were present from the student protests to the assassination of Bobby Kennedy; from Nixon's rise and fall to the healing years of Ford and Carter; from the first attempts at Middle East diplomacy to the advent of Reaganism and the crumbling of the Soviet Union; from the Clinton and Bush dynasties to an exploration of life in America during the year after 9/11; all the way to the most important events of the past few years.

Along the way, David served as President Ford's personal White House photographer and has stayed close with the family and continued to document their life since.

It seemed only natural that he was the ideal person to capture the amazing stories that are unfolding at NewYork-Presbyterian Hospital. Stories that, in their own way, are poignant and significant in the evolution of the human saga. David had never done a project like this before. We asked. Fortunately, he said yes.

Lead Researcher

Dr. Steven Rosenfeld

Dr. Rosenfeld is the John and Elizabeth Harris Professor of Neurology, Head of the Division of Neuro-Oncology in the Department of Neurology, College of Physicians and Surgeons of Columbia University, and Co-Director of the Brain Tumor Center at the New York-Presbyterian Hospital.

After completing his training, he joined the medical school faculty at the University of Alabama at Birmingham, and assumed directorship of its Brain Tumor Program in 1995. Under his leadership, the UAB Brain Tumor Program underwent a marked expansion in both clinical and translational research, enabling it to achieve a position of national prominence. This culminated in Dr. Rosenfeld's being awarded a Brain Cancer Specialized Center of Research Excellence (SPORE) grant by the National Cancer Institute in 2002 – one of only two nation-wide.

Dr. Rosenfeld's research, which has been funded by the National Cancer Institute and the National Institute of Neurological Diseases and Stroke, focuses on novel ways of pharmacologically-blocking brain tumor growth and invasiveness by targeting the molecular motors that drive mitosis and cell motility.

He is a Fellow of the American Neurological Association, has served as a member of the Editorial Board of the Journal of Biological Chemistry, is a peer reviewer for over 15 scientific journals, and is a member of the Developmental Therapeutics study section. He has also served as the Educational Program Director for the Society for Neuro-Oncology (1999) and as a member of the NCI/NINDS Progress Review Group in Neuro-Oncology.